CVS testing explained

What CVS testing is

Chorionic villus sampling is a prenatal diagnostic procedure in which a clinician obtains a very small sample of chorionic villi, the tiny fingerlike projections in the placenta. These cells usually share the fetus’s genetic material because the placenta and fetus develop from the same fertilized egg. The laboratory can then analyze the sample for chromosome number or structure and, when indicated, specific single-gene disorders.

CVS is different from first trimester prenatal screening. Screening tests, such as blood tests, nuchal translucency ultrasound, or cell-free DNA screening, estimate the chance that a pregnancy may be affected by certain conditions. They do not confirm a diagnosis. CVS is considered diagnostic because it directly examines tissue for genetic information. In many situations, it can provide a much clearer answer than screening, although no test is perfect and some results require careful interpretation.

The conditions commonly evaluated through CVS include chromosome disorders such as trisomy 21, trisomy 18, trisomy 13, and sex chromosome aneuploidies. If there is a known familial variant, CVS may also be used to test for inherited disorders such as cystic fibrosis, sickle cell disease, Tay-Sachs disease, or other single-gene conditions, depending on the family history and available laboratory methods. The exact test ordered matters: a karyotype, chromosomal microarray, targeted molecular test, or other genetic assay can answer different questions.

When CVS is usually offered

CVS is usually performed early in pregnancy, most often after 10 weeks and before the end of the first trimester, although timing varies by institution and clinical details. This early timing is one reason some people consider CVS: it can provide diagnostic information sooner than amniocentesis, which is typically performed later.

A clinician may discuss CVS for several reasons. These include a high-chance result on prenatal screening, an ultrasound finding that raises concern for a chromosome or genetic condition, a previous pregnancy affected by a genetic disorder, a parent known to carry a chromosome rearrangement, or a family history suggesting a specific inherited disease. Some people also consider diagnostic testing because they want the most definitive information available, even if screening results are not concerning.

Being offered CVS does not mean something is definitely wrong. It means there is a medical reason to discuss whether direct fetal-placental genetic testing would be useful. This discussion is often best supported by genetic counseling, where the clinician can review what condition is being considered, what the test can detect, how accurate the expected result is, and what choices the information may affect.

How the CVS procedure is performed

CVS is performed by a trained clinician using continuous ultrasound guidance. Ultrasound helps confirm pregnancy location, gestational age, fetal heartbeat, placental position, and the safest route to the placenta. The procedure may be transabdominal or transcervical, and the route is chosen based on anatomy, placental location, clinician expertise, and safety considerations.

In transabdominal CVS, the abdomen is cleaned, and a thin needle is passed through the abdominal wall and uterus into the placenta under ultrasound guidance. A small amount of placental tissue is aspirated. Some practices use local anesthetic, while others may not, depending on technique and patient factors. People often describe cramping, pressure, or a brief sharp sensation, but experiences vary.

In transcervical CVS, a speculum is placed in the vagina, the cervix is cleaned, and a thin catheter is guided through the cervix to the placenta while ultrasound monitors positioning. A small tissue sample is then removed. This approach may feel similar to a pelvic exam combined with cramping or pressure.

The actual sampling usually takes only a short time, though the appointment may be longer because of counseling, ultrasound assessment, preparation, and post-procedure observation. If the first sample is insufficient, the clinician may need to obtain more tissue, but this is balanced carefully against procedural risk. Afterward, mild cramping or light spotting can occur, and the care team should explain what symptoms require urgent contact.

What CVS can and cannot tell you

CVS can usually diagnose many chromosome conditions with high certainty when the sample is adequate and the laboratory test is appropriate for the question being asked. It can identify extra or missing chromosomes, many large structural chromosome changes, and selected genetic variants when targeted testing is ordered. For families with a known inherited condition, this early diagnostic information can be especially meaningful.

However, CVS cannot answer every question about fetal health. It does not evaluate open neural tube defects such as spina bifida, because that assessment typically relies on second trimester maternal serum alpha-fetoprotein testing and detailed ultrasound. CVS also does not rule out all congenital anomalies, all developmental conditions, or every genetic variant. A normal CVS result can be very reassuring for the conditions tested, but it is not a guarantee that the baby will have no medical problems.

One important limitation is confined placental mosaicism. This occurs when the placenta contains a chromosomal cell line that is different from the fetus, or when not all placental cells have the same result. Because CVS samples placental tissue, a mosaic result may need follow-up testing, sometimes including amniocentesis, to clarify the fetal chromosome status. Rarely, maternal cell contamination or technical limitations can also affect interpretation.

For this reason, results should be reviewed with a clinician who can explain the laboratory method, residual uncertainty, and whether additional testing or ultrasound follow-up is recommended. The most useful question is not only “Is the result normal?” but “What exactly was tested, and what remains outside the scope of this result?”

Benefits, risks, and emotional considerations

The main benefit of CVS is early diagnostic information. For some families, earlier answers reduce uncertainty and help them prepare medically, emotionally, and practically. If a serious condition is diagnosed, families may use the information to arrange specialist consultations, plan delivery at an appropriate center, consider pregnancy options, or prepare for neonatal care. If the result is reassuring, it may ease anxiety after a concerning screening result.

CVS is optional. It is not a routine requirement of pregnancy care, and declining it is a valid decision. Some people prefer noninvasive screening first, some choose amniocentesis later, and others decide that diagnostic testing does not align with their values or risk tolerance. A supportive clinician should help you make an informed choice without pressure.

Because CVS is invasive, it carries risks. These may include cramping, bleeding or spotting, infection, leakage of fluid, sensitization concerns for people who are Rh-negative, and a small risk of pregnancy loss. The exact risk estimate depends on procedural route, operator experience, gestational age, individual pregnancy factors, and the reason for testing. Your own care team is the best source for center-specific risk information.

The emotional side deserves attention. Waiting for results can be difficult, and diagnostic information may create complex decisions. Many people find it helpful to ask in advance how results will be delivered, who will interpret them, whether rapid preliminary results are available, and what support is available if the result is unexpected.

Preparing for the appointment and recovery afterward

Before CVS, you will usually have an ultrasound and a consent discussion. Bring any relevant screening reports, prior pregnancy records, family genetic test results, and a list of medications or allergies. If a specific inherited condition is being evaluated, the laboratory often needs precise documentation of the familial variant before the procedure, so early coordination is important.

Ask whether you need a full or empty bladder, whether you can eat beforehand, and whether someone should accompany you. Many people can return to light activity after the procedure, but your clinician may advise avoiding strenuous exercise, heavy lifting, or intercourse for a short period. Follow the instructions provided by your own clinic, because recommendations vary.

After CVS, contact your healthcare team promptly if you have heavy bleeding, fever, worsening abdominal pain, fluid leakage, contractions, foul-smelling discharge, or any symptom your clinician specifically warned you about. Mild cramping or minimal spotting can happen, but it should not be ignored if it becomes persistent or severe.

Results may come in stages. Some tests can provide preliminary information relatively quickly, while full chromosome analysis, microarray, or targeted molecular testing may take longer. Ask what each result category means and whether any result is considered preliminary. If the report uses terms such as variant of uncertain significance, mosaicism, deletion, duplication, or balanced translocation, genetic counseling can help translate the findings into practical implications.

CVS compared with amniocentesis and screening tests

CVS, amniocentesis, and screening tests serve different roles in prenatal testing. Screening tests are noninvasive and can estimate risk, but they cannot confirm most diagnoses. CVS provides diagnostic information earlier by sampling placental tissue. Amniocentesis, performed later, samples amniotic fluid containing fetal cells and can also measure markers related to open neural tube defects in many settings.

The choice is not simply about which test is “better.” It depends on timing, the condition being evaluated, ultrasound findings, family history, how urgently information is needed, and the person’s preferences about procedure-related risk. For example, CVS may be attractive when early diagnosis of a known familial condition is needed. Amniocentesis may be preferred if there is concern about confined placental mosaicism or if neural tube defect assessment is central to the question.

A practical decision pathway often begins with clarifying the clinical question. Are you trying to confirm a high-chance screening result for trisomy 21? Test for a known single-gene disorder? Investigate an ultrasound anomaly? Understand a parental chromosome rearrangement? Once the question is defined, your clinician can recommend the most appropriate diagnostic method and laboratory analysis.